Nexcelom’s CTO on the Future of CAR T Workflow

Nexcelom founder and CTO, Dr. Jean Qiu, describes 3 major reasons why we partner with global and local research organizations to streamline CAR-T workflow.

By |2019-01-15T20:49:37+00:00January 15th, 2019|Categories: Accurate Cell Counting, Latest News|Tags: , , , , |0 Comments

Advantages of a Standardized Automated Cell Counting Method for Cell Therapy

Q & A regarding the crucial need for accurate and consistent cell counting methods for development and manufacturing of CAR-T under GMP/GLP conditions.

By |2018-12-13T19:46:26+00:00December 13th, 2018|Categories: Accurate Cell Counting, Latest News|Tags: , |0 Comments